Product Specifications
| Fermentation Smell | Normal Smell | Temperature Needed For
Fermentation |
10-25 Celsius (0C) |
| Enzymatic Activity | No | Physical Color/Texture | Other |
| Shelf Lite | 1-2 Year | Enzyme Types | Other |
| Storage Instructions | Store at Dry Place and cool place | Ingredients | Other |
| Ph Level | 3-5 | Feature | Other |
Product Description
Osimertinib is a targeted therapy medication used in the treatment of non-small cell lung cancer (NSCLC), specifically for patients with certain mutations in the epidermal growth factor receptor (EGFR) gene. Here are some general specifications for osimertinib tablets based on my knowledge as of September 2021. Please keep in mind that specific product information and guidelines may vary, so it’s essential to consult with a healthcare professional or refer to the latest medical literature or product packaging for the most up-to-date information.
Generic Name: Osimertinib
Indications: Osimertinib is primarily used for the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) in patients who have EGFR mutations, specifically T790M mutations. It is not typically used as a first-line treatment but may be prescribed after other EGFR-targeted therapies have stopped working.
Dosage: The dosage of osimertinib can vary depending on the patient’s specific condition and the treatment plan recommended by a healthcare provider. It is typically taken orally in the form of tablets.
Mechanism of Action: Osimertinib is an EGFR tyrosine kinase inhibitor (TKI). It works by blocking the activity of mutant EGFR proteins, which are often responsible for the growth and spread of NSCLC cells in patients with EGFR mutations.
Common Side Effects: Common side effects of osimertinib may include diarrhea, rash, dry skin, nausea, fatigue, and changes in liver function tests. Patients should be monitored for these and other potential side effects.
Special Precautions: Osimertinib should only be prescribed by healthcare professionals experienced in the use of targeted therapies for cancer. It is important to inform your healthcare provider about any other medications you may be taking and any underlying health conditions.
Pregnancy and Breastfeeding: Osimertinib can harm unborn babies, so it should not be used during pregnancy. Effective contraception should be used during treatment, and women should avoid becoming pregnant while taking osimertinib. It is not recommended during breastfeeding, and women should discontinue breastfeeding while on this medication.
Please note that the information provided here is based on my knowledge as of September 2021, and there may have been developments or changes in the specifications or usage guidelines for osimertinib tablets since then. Always consult a healthcare professional or refer to the latest medical resources for the most current and accurate information regarding any medication.
